Company intelligence / Profile preview

Navana Pharmaceuticals

Dhaka, Bangladesh

Ownership: Private
Employees: ~4080
Development stage: Other

Overview

Navana Pharmaceuticals is a diversified Bangladeshi pharmaceutical manufacturer with more than 277 human health products and over 123 veterinary products on the market. The company is commercially active, with ongoing domestic and export operations and consistent revenue growth. No proprietary clinical-stage pipeline or unique platform technologies are disclosed.

Therapeutic areas: CardiovascularOphthalmologyGastroenterologyInfectious DiseasesNeurologyOther
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Navana Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Navana Pharmaceuticals.

Explore the full profile